Journal articles: 'Proton magnetic resonance spectroscopy'

1

McQuarrie, Donald A. "Proton magnetic resonance spectroscopy." Journal of Chemical Education 65, no. 5 (May 1988): 426. http://dx.doi.org/10.1021/ed065p426.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Cecil, Kim M. "Proton Magnetic Resonance Spectroscopy." Neuroimaging Clinics of North America 23, no. 3 (August 2013): 381–92. http://dx.doi.org/10.1016/j.nic.2012.10.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Zimmerman, Robert A., and Zhiyue Wang. "Proton magnetic resonance spectroscopy." Critical Reviews in Neurosurgery 9, no. 3 (March 1999): 161–66. http://dx.doi.org/10.1007/s003290050126.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Linfante, Italo, and Tetsuo Ashizawa. "Proton Magnetic Resonance Spectroscopy." Archives of Neurology 56, no. 12 (December 1, 1999): 1446. http://dx.doi.org/10.1001/archneur.56.12.1446.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Bertholdo, Débora, Arvemas Watcharakorn, and Mauricio Castillo. "Brain Proton Magnetic Resonance Spectroscopy." Neuroimaging Clinics of North America 23, no. 3 (August 2013): 359–80. http://dx.doi.org/10.1016/j.nic.2012.10.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Goenka, Surabhi, Anand Kalegowda, Deepthi Naik, and Ashok Kumar. "Diagnostic Efficacy of Proton Magnetic Resonance Spectroscopy and Diffusion Weighted Imaging in Cerebral Gliomas." International Journal of Neurology and Neurosurgery 9, no. 2 (2017): 83–92. http://dx.doi.org/10.21088/ijnns.0975.0223.9217.2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Rao, NarenP, BangaloreN Gangadhar, and Ganesan Venkatasubramanian. "Proton magnetic resonance spectroscopy in depression." Indian Journal of Psychiatry 53, no. 4 (2011): 307. http://dx.doi.org/10.4103/0019-5545.91903.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Bertolino, Alessandro, and Daniel R. Weinberger. "Proton magnetic resonance spectroscopy in schizophrenia." European Journal of Radiology 30, no. 2 (May 1999): 132–41. http://dx.doi.org/10.1016/s0720-048x(99)00052-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Delamillieure, P., J. M. Constans, J. Fernandez, P. Brazol, T. Vasse, P. Courtheoux, M. Petit, and S. Dollfus. "Proton magnetic resonance spectroscopy and schizophrenia." Schizophrenia Research 29, no. 1-2 (January 1998): 100. http://dx.doi.org/10.1016/s0920-9964(97)88553-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Shiino, Akihiko, Masayuki Matsuda, Shigehiro Morikawa, Toshiro Inubushi, Ichiro Akiguchi, and Jyoji Handa. "Proton magnetic resonance spectroscopy with dementia." Surgical Neurology 39, no. 2 (February 1993): 143–47. http://dx.doi.org/10.1016/0090-3019(93)90093-g.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Malhotra, D., J. I. Shapiro, and L. Chan. "Nuclear magnetic resonance spectroscopy in patients with anion-gap acidosis." Journal of the American Society of Nephrology 2, no. 5 (November 1991): 1046–50. http://dx.doi.org/10.1681/asn.v251046.

Full text

Abstract:

Proton nuclear magnetic resonance spectroscopy was performed on blood or urine from five patients with an anion-gap metabolic acidosis. In all of these cases, this methodology allowed the rapid and specific diagnosis of the nature of the metabolic acidosis. In several of these patients, spectroscopic evidence for intoxication with toxic alcohols was obtained. On the basis of these preliminary data, proton nuclear magnetic resonance spectroscopy may be a useful technique in the evaluation of patients with anion-gap acidosis.

APA, Harvard, Vancouver, ISO, and other styles

12

Sener, R. Nuri. "Phenylketonuria: Diffusion Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy." Journal of Computer Assisted Tomography 27, no. 4 (July 2003): 541–43. http://dx.doi.org/10.1097/00004728-200307000-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Wolinsky, J. S., P. A. Narayana, and M. J. Fenstermacher, MD. "Proton magnetic resonance spectroscopy in multiple sclerosis." Neurology 40, no. 11 (November 1, 1990): 1764. http://dx.doi.org/10.1212/wnl.40.11.1764.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Federico, F., I. L. Simone, V. Lucivero, G. Defazio, R. De Salvia, D. M. Mezzapesa, M. Petruzzellis, C. Tortorella, and P. Livrea. "Proton magnetic resonance spectroscopy in primary blepharospasm." Neurology 51, no. 3 (September 1, 1998): 892–95. http://dx.doi.org/10.1212/wnl.51.3.892.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

McNatt, Sean A., J. Gordon McComb, Marvin D. Nelson, and Stefan Bluml. "Proton Magnetic Resonance Spectroscopy of Hydrocephalic Infants." Pediatric Neurosurgery 43, no. 6 (2007): 461–67. http://dx.doi.org/10.1159/000108788.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Chen, Yaqing, Mingjuan Liu, and Yan Guo. "Proton Magnetic Resonance Spectroscopy in Prostate Tuberculosis." Urology 75, no. 5 (May 2010): 1065–66. http://dx.doi.org/10.1016/j.urology.2009.06.069.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Sajja, Balasrinivasa R., Jerry S. Wolinsky, and Ponnada A. Narayana. "Proton Magnetic Resonance Spectroscopy in Multiple Sclerosis." Neuroimaging Clinics of North America 19, no. 1 (February 2009): 45–58. http://dx.doi.org/10.1016/j.nic.2008.08.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Isobe, Tomonori, Tetsuya Yamamoto, Hiroyoshi Akutsu, Izumi Anno, Masanari Shiigai, Alexander Zaboronok, Tomohiko Masumoto, Shingo Takano, and Akira Matsumura. "Proton magnetic resonance spectroscopy findings of hemangioblastoma." Japanese Journal of Radiology 28, no. 4 (May 2010): 318–21. http://dx.doi.org/10.1007/s11604-010-0421-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Kinoshita, Yoshimasa, Hidehiko Kajiwara, Akira Yokota, and Yosuke Koga. "Proton Magnetic Resonance Spectroscopy of Brain Tumors." Neurosurgery 35, no. 4 (October 1, 1994): 606–14. http://dx.doi.org/10.1227/00006123-199410000-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Lee, Chieh-Hsun, Ping-Hong Lai, Chin-San Liu, and Jie-Yuan Li. "Proton magnetic resonance spectroscopy in Kennedy disease." Journal of the Neurological Sciences 277, no. 1-2 (February 2009): 71–75. http://dx.doi.org/10.1016/j.jns.2008.10.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Coulthard, E., M. Firbank, P. English, J. Welch, D. Birchall, J. O’Brien, and T. D. Griffiths. "Proton magnetic resonance spectroscopy in frontotemporal dementia." Journal of Neurology 253, no. 7 (July 2006): 861–68. http://dx.doi.org/10.1007/s00415-006-0045-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Moore, Gregory J. "Proton magnetic resonance spectroscopy in pediatric neuroradiology." Pediatric Radiology 28, no. 11 (November 3, 1998): 805–14. http://dx.doi.org/10.1007/s002470050470.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Wolinsky, JerryS, and PonnadaA Narayana. "Proton magnetic resonance spectroscopy and multiple sclerosis." Lancet 337, no. 8737 (February 1991): 362. http://dx.doi.org/10.1016/0140-6736(91)90989-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Kinoshita, Yoshimasa, Hidehiko Kajiwara, Akira Yokota, and Yosuke Koga. "Proton Magnetic Resonance Spectroscopy of Brain Tumors." Neurosurgery 35, no. 4 (October 1994): 606???614. http://dx.doi.org/10.1097/00006123-199410000-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Connelly, Alan. "Proton Magnetic Resonance Spectroscopy (MRS) in Epilepsy." Epilepsia 38, s10 (October 1997): 33–38. http://dx.doi.org/10.1111/j.1528-1157.1997.tb00090.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Karitzky, Jochen, Wolfgang Block, Jörg K. Mellies, Frank Träber, Anne Sperfeld, Hans H. Schild, Peter Haller, and Albert C. Ludolph. "Proton Magnetic Resonance Spectroscopy in Kennedy Syndrome." Archives of Neurology 56, no. 12 (December 1, 1999): 1465. http://dx.doi.org/10.1001/archneur.56.12.1465.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Story, Lisa, Mellisa S. Damodaram, Joanna M. Allsop, Amy McGuinness, Marzena Wylezinska, Sailesh Kumar, and Mary A. Rutherford. "Proton magnetic resonance spectroscopy in the fetus." European Journal of Obstetrics & Gynecology and Reproductive Biology 158, no. 1 (September 2011): 3–8. http://dx.doi.org/10.1016/j.ejogrb.2010.03.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Popli, Manju Bala, Archana Kumari, and Vineet Popli. "Proton magnetic resonance spectroscopy in breast tuberculosis." European Journal of Radiology Extra 74, no. 3 (June 2010): e59-e63. http://dx.doi.org/10.1016/j.ejrex.2010.04.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Jung, Rex E., Charles Gasparovic, Robert S. Chavez, Arvind Caprihan, Ranee Barrow, and Ronald A. Yeo. "Imaging intelligence with proton magnetic resonance spectroscopy." Intelligence 37, no. 2 (March 2009): 192–98. http://dx.doi.org/10.1016/j.intell.2008.10.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Cakirer, S., B. Yagmurlu, and M. R. Savas. "Sturge‐weber syndrome: diffusion magnetic resonance imaging and proton magnetic resonance spectroscopy findings." Acta Radiologica 46, no. 4 (July 2005): 407–10. http://dx.doi.org/10.1080/02841850510021274.

Full text

Abstract:

We report on the diffusion magnetic resonance imaging (MRI) and proton MR spectroscopy findings of a 26‐year‐old female patient with Sturge‐Weber syndrome. Echo‐planar trace diffusion MRI revealed mildly high signal intensity changes at parieto‐occipital lobes on b = 1000 s/mm2 images, suggesting restricted diffusion. On corresponding apparent diffusion coefficient maps, those areas had moderately high signal intensity and high apparent diffusion coefficient values (around 0.9×10(−3) mm2/s) compared with the contralateral symmetrical normal side of the brain (0.776×10(−3) mm2/s). This finding was consistent with increased motion of water molecules (disintegration of the neural tissue) in these regions. Proton MR spectroscopy revealed decreased N‐acetyl aspartate and increased choline peaks, indicating disintegration of neural tissue associated with neuronal loss as well.

APA, Harvard, Vancouver, ISO, and other styles

31

Garg, Varun. "Evaluation of Intracranial Ring Lesions by Diffusion-Weighted Imaging and in Vivo Proton Magnetic Resonance Spectroscopy." Journal of Medical Science And clinical Research 04, no. 11 (November 14, 2016): 13929–34. http://dx.doi.org/10.18535/jmscr/v4i11.69.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Hascalik, S., O. Celik, G. Erdem, C. Ara, and H. Kirimlioglu. "Proton magnetic resonance spectroscopy findings of a sacrococcygeal schwannoma." International Journal of Gynecologic Cancer 16, Suppl 1 (January 2006): 344–48. http://dx.doi.org/10.1136/ijgc-00009577-200602001-00060.

Full text

Abstract:

Schwannoma is tumor of peripheral nerves, originating from Schwann cells. It is a rare nerve sheath tumor, which frequently occurs in the intracranial acoustic nerve and spinal nerves. We report on a 28-year-old woman who suffered from a large pelvic mass that was diagnosed to be sacrococcygeal schwannoma. The features of proton magnetic resonance spectroscopy (MRS) study are discussed. The magnetic resonance imaging instrument was a 1.5T, Gyroscan Intera with a body coil as a radiofrequency transmitter and a signal receiver. T2-weighted images were obtained under the following conditions—turbo spin echo (TSE) T2: turbo spin echo repeat time (TR) = 4500 msec, echo time (TE) = 96 msec. Single voxel MRS was performed by the point-resolved spectroscopy technique with a long TE (136 msec). MRS measurement was performed on two different parts of the tumor. As well as strongly elevated choline and lipid signals, the tumor spectrum showed increased N-acetylaspartate resonances. MRS can be used effectively in the preoperative diagnosis of retroperitoneal and pelvic masses, which demonstrate unusual clinical features.

APA, Harvard, Vancouver, ISO, and other styles

33

Quadrelli, Scott, Carolyn Mountford, and Saadallah Ramadan. "Hitchhiker'S Guide to Voxel Segmentation for Partial Volume Correction of in Vivo Magnetic Resonance Spectroscopy." Magnetic Resonance Insights 9 (January 2016): MRI.S32903. http://dx.doi.org/10.4137/mri.s32903.

Full text

Abstract:

Partial volume effects have the potential to cause inaccuracies when quantifying metabolites using proton magnetic resonance spectroscopy (MRS). In order to correct for cerebrospinal fluid content, a spectroscopic voxel needs to be segmented according to different tissue contents. This article aims to detail how automated partial volume segmentation can be undertaken and provides a software framework for researchers to develop their own tools. While many studies have detailed the impact of partial volume correction on proton magnetic resonance spectroscopy quantification, there is a paucity of literature explaining how voxel segmentation can be achieved using freely available neuroimaging packages.

APA, Harvard, Vancouver, ISO, and other styles

34

Graham, Glenn D. "Brain Macromolecules: In Vivo Measurement by Proton Magnetic Resonance Spectroscopy." Neuroscientist 2, no. 6 (November 1996): 309–12. http://dx.doi.org/10.1177/107385849600200607.

Full text

Abstract:

New single- and multiple-volume in vivo proton magnetic resonance spectroscopy techniques detect signals from brain macromolecules and can separate them from overlapping small molecule resonances. In vitro and animal studies have identified these resonances as arising from cytosolic proteins and mobile lipids. Increased macromolecule signals from lipids have been detected in both subacute stroke and in active multiple sclerosis plaques that reflect tissue breakdown and, in conjunction with elevated lactate, can be used to monitor phagocytic cell activity. The ability to follow changes in brain lipids and proteins should help to elucidate biochemical abnormalities accompanying a variety of pathological conditions.

APA, Harvard, Vancouver, ISO, and other styles

35

Ramin, Sérgio Luiz, Waldir Antonio Tognola, and Antonio Ronaldo Spotti. "Proton magnetic resonance spectroscopy: clinical applications in patients with brain lesions." Sao Paulo Medical Journal 121, no. 6 (2003): 254–59. http://dx.doi.org/10.1590/s1516-31802003000600008.

Full text

Abstract:

CONTEXT: Proton spectroscopy has been recognized as a safe and noninvasive diagnostic method that, coupled with magnetic resonance imaging techniques, allows for the correlation of anatomical and physiological changes in the metabolic and biochemical processes occurring within previously-determined volumes in the brain. There are two methods of proton magnetic resonance spectroscopy: single voxel and chemical shift imaging OBJECTIVE: The present work focused on the clinical applications of proton magnetic resonance spectroscopy in patients with brain lesions. CONCLUSIONS: In vivo proton spectroscopy allows the detection of certain metabolites in brain tissue, such as N-acetyl aspartate, creatine, choline, myoinositol, amino acids and lipids, among others. N-acetyl aspartate is a neuronal marker and, as such, its concentration will decrease in the presence of aggression to the brain. Choline increase is the main indicator of neoplastic diseases. Myoinositol is raised in patients with Alzheimer's disease. Amino acids are encountered in brain abscesses. The presence of lipids is related to necrotic processes.

APA, Harvard, Vancouver, ISO, and other styles

36

Cobbold, Jeremy F. L., Simon D. Taylor-Robinson, and I. Jane Cox. "In vitroproton magnetic resonance spectroscopy of liver tissue informsin vivohepatic proton magnetic resonance spectroscopy studies." Hepatology 48, no. 3 (September 2008): 1016. http://dx.doi.org/10.1002/hep.22453.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Nguyen, Jeremy B., Naveed Ahktar, Pablo N. Delgado, and Lisa H. Lowe. "Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy of Intracranial Epidermoid Tumors." Critical Reviews in Computed Tomography 45, no. 5-6 (January 2004): 389–427. http://dx.doi.org/10.3109/10408370490903543.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Duara, Bijit Kumar, Pradipta Ray Choudhury, and Ganesan Gopinath. "Magnetic resonance spectroscopic evaluation of intracranial tumors in adults." National Journal of Clinical Anatomy 04, no. 02 (April 2015): 67–75. http://dx.doi.org/10.1055/s-0039-3401553.

Full text

Abstract:

Abstract Background and Aims: There is a lot of scope for Magnetic Resonance spectroscopy as a tool in diagnosing brain tumors in conjunction with conventional Magnetic Resonance sequences. It is considered to be a non invasive way to get the neurochemistry which will predict the histopathological diagnosis thereby preventing unnecessary surgery and associated morbidity. Here, a Magnetic Resonance spectroscopic imaging study of intra cranial tumors in adults was undertaken to assess the diagnostic usefulness of magnetic resonance spectroscopy in brain tumors. Materials & Methods: In the present study, 40 cases of brain tumors were included, among which 25 were male and rest were female with mean age 45 years. Results: The pathological 'H-MRS (proton magnetic resonance spectroscopy) spectra for various types of brain tumor were studied and tabulated. Conclusion: Magnetic Resonance Spectroscopy is a noninvasive, cost effective and easily repeatable when compared to the conventional brain biopsy procedure. Therefore brain tumor MR imaging should always complemented with dedicated spectroscopy sequences to deal with diagnostic dilemmas and improve patient treatment.

APA, Harvard, Vancouver, ISO, and other styles

39

Otvos, J. D., E. J. Jeyarajah, and D. W. Bennett. "Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy." Clinical Chemistry 37, no. 3 (March 1, 1991): 377–86. http://dx.doi.org/10.1093/clinchem/37.3.377.

Full text

Abstract:

Abstract A new analytical procedure for quantifying plasma lipoproteins by proton nuclear magnetic resonance (NMR) spectroscopy has been developed that potentially offers significant advantages over existing clinical methods used for assessing risk of coronary heart disease. Analysis of a single spectrum of a nonfasting plasma sample, acquired simply and rapidly at moderate magnetic field strength (250 MHz), yields a complete profile of lipoprotein concentrations: chylomicrons and very-low-, low-, and high-density lipoproteins. The method is based on curve-fitting (spectral deconvolution) of the plasma methyl lipid resonance envelope, the amplitude and shape of which depend directly on the amplitudes of the superimposed methyl resonances of the lipoprotein components. A linear least-squares curve-fitting algorithm was developed to efficiently extract the signal amplitudes (concentrations) of the lipoproteins from the plasma spectrum. These signal amplitudes correlate well with lipoprotein concentrations determined by triglyceride and cholesterol measurements.

APA, Harvard, Vancouver, ISO, and other styles

40

Trofimova, T. N., A. D. Khalikov, M. D. Semenova, and A. A. Bogdan. "PRENATAL PROTON MAGNETIC RESONANCE SPECTROSCOPY OF THE BRAIN." Diagnostic radiology and radiotherapy, no. 2 (August 4, 2019): 5–14. http://dx.doi.org/10.22328/2079-5343-2019-10-2-5-14.

Full text

Abstract:

The article demonstrates the first Russian experience of prenatal proton magnetic resonance spectroscopy (1Н MRS) of the brain. The results of the study are analyzed, the metabolic changes during the gestation period is evaluated. Neuroimaging methods of assessing brain metabolism may play a role in the diagnosis and prognosis of some perinatal neurological disorders, that is why the information about normal cerebral metabolic processes is extremely important. Prenatal 1Н MRS of the brain is an informative, non invasive diagnostic method that is performed complementary to MRI and provides unique information about the cerebral biochemical composition. Brain metabolic changes may precede structural, e.g. the appearance of changes in the spectrograms may outgo the changes in traditional MRI, therefore, the method may be useful in the early detection of a pathology. Early detection of abnormal metabolic brain processes may be helpful in identifying future potential therapeutic strategies.

APA, Harvard, Vancouver, ISO, and other styles

41

YANG, Jie, Shiping ZHANG, Wei SUN, and Yinjuan BAI. "Proton Nuclear Magnetic Resonance Spectroscopy of Active Hydrogen." University Chemistry 34, no. 1 (2019): 82–88. http://dx.doi.org/10.3866/pku.dxhx201806008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Szulc, Agata, Beata Galinska-Skok, Napoleon Waszkiewicz, Daniel Bibulowicz, Beata Konarzewska, and Eugeniusz Tarasow. "Proton Magnetic Resonance Spectroscopy Changes After Antipsychotic Treatment." Current Medicinal Chemistry 20, no. 3 (January 1, 2013): 414–27. http://dx.doi.org/10.2174/092986713804870783.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Szulc, Agata, Beata Galinska-Skok, Napoleon Waszkiewicz, Daniel Bibulowicz, Beata Konarzewska, and Eugeniusz Tarasow. "Proton Magnetic Resonance Spectroscopy Changes After Antipsychotic Treatment." Current Medicinal Chemistry 20, no. 3 (January 1, 2013): 414–27. http://dx.doi.org/10.2174/0929867311320030013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Sutton, Leslie N., Zhiyue Wang, Debra Gusnard, Beverly Lange, Giorgio Perilongo, Andrew R. Bogdan, John A. Detre, Lucy Rorke, and Robert A. Zimmerman. "Proton Magnetic Resonance Spectroscopy of Pediatric Brain Tumors." Neurosurgery 31, no. 2 (August 1992): 195???202. http://dx.doi.org/10.1097/00006123-199208000-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Graham, G. D., O. A. C. Petroff, A. M. Blamire, G. Rajkowska, P. Goldman-Rakic, and J. W. Prichard. "Proton magnetic resonance spectroscopy in Creutzfeldt-Jakob disease." Neurology 43, no. 10 (October 1, 1993): 2065. http://dx.doi.org/10.1212/wnl.43.10.2065.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Özdemir, M. S., Y. De Deene, E. Fieremans, and I. Lemahieu. "Quantitative proton magnetic resonance spectroscopy without water suppression." Journal of Instrumentation 4, no. 06 (June 15, 2009): P06014. http://dx.doi.org/10.1088/1748-0221/4/06/p06014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Tükel, Raşit, Kubilay Aydın, Çağrı Yüksel, Erhan Ertekin, and Ahmet Koyuncu. "Proton Magnetic Resonance Spectroscopy in Social Anxiety Disorder." Journal of Neuropsychiatry and Clinical Neurosciences 28, no. 2 (April 2016): 138–42. http://dx.doi.org/10.1176/appi.neuropsych.15050115.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Zorzon, M. "Proton magnetic resonance spectroscopy during transient global amnesia." Neurocase 6, no. 3 (June 1, 2000): 230a—230. http://dx.doi.org/10.1093/neucas/6.3.230-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Das, Chandan Jyoti, and Kunjahari Medhi. "Proton Magnetic Resonance Spectroscopy of Tubercular Breast Abscess." Journal of Computer Assisted Tomography 32, no. 4 (July 2008): 599–601. http://dx.doi.org/10.1097/rct.0b013e31814b143e.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Imbesi, Steven G. "Proton Magnetic Resonance Spectroscopy of Mesial Temporal Sclerosis." Journal of Computer Assisted Tomography 30, no. 2 (March 2006): 287–94. http://dx.doi.org/10.1097/00004728-200603000-00024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Journal articles on the topic 'Proton magnetic resonance spectroscopy'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles